Outset Medical (OM) Receivables (2019 - 2026)

Outset Medical (OM) has reported Receivables for 8 consecutive years, with $29.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Receivables fell 16.24% year-over-year to $29.2 million in Q2 2026; TTM through Jun 2026 was $29.2 million, a 16.24% decrease from a year earlier, with the FY2025 full-year figure at $28.3 million, down 20.47% from the prior year.
• Receivables was $29.2 million for Q2 2026 at Outset Medical, up from $25.3 million in the prior quarter.
• Over five years, Receivables peaked at $36.9 million in Q2 2023 and troughed at $22.5 million in Q3 2022.
• A 5-year average of $31.7 million and a median of $33.6 million in 2023 frame the typical range for Receivables.
• Across the five-year window, Receivables soared 122.12% in 2022 and plunged 31.36% in 2026, its largest moves.
• Over 5 years, Receivables stood at $28.1 million in 2022, then grew by 17.49% to $33.0 million in 2023, then rose by 8.0% to $35.6 million in 2024, then slipped by 20.47% to $28.3 million in 2025, then gained by 3.16% to $29.2 million in 2026.
• The last three Receivables figures came in at $29.2 million (Q2 2026), $25.3 million (Q1 2026), and $28.3 million (Q4 2025), per Business Quant data.